Westchester Capital Management (New York)’s Celgene Corp CELG Stock Holding History

Westchester Capital Management (New York)’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,682,439	Closed	-$167M	–	198
2019 Q3	$167M	Buy	1,682,439 +372,409	+28%	+$35.4M	6.5%	2
2019 Q2	$121M	Buy	1,310,030 +300,116	+30%	+$28.5M	3.95%	9
2019 Q1	$95.3M	Buy	+1,009,914	New	+$88.3M	3.51%	8

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Westchester Capital Management (New York)'s CELG Position: Q4 2019 in Review

Westchester Capital Management (New York) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,682,439 shares — an estimated $167M sold.

Westchester Capital Management (New York) first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $167M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Westchester Capital Management (New York) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Westchester Capital Management (New York) sold 1,682,439 Celgene Corp shares in Q4 2019, an estimated $167M.
Westchester Capital Management (New York) first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Westchester Capital Management (New York)'s Celgene Corp position peaked at $167M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.